Paper3000612
High frequency of homologous recombination in mammalian cells between endogenous and introduced SV40 genomes.
Jasin M and 3 others. Cell, 1985. Cited by 90 papers, by iCite.
Cite this record
ConductScience Library. High frequency of homologous recombination in mammalian cells between endogenous and introduced SV40 genomes. Papers, record 3000612. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3000612
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- High frequency of homologous recombination in mammalian cells between endogenous and introduced SV40 genomes.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| DNA, Recombinant | Major topic |
| DNA, Viral | Major topic |
| Genes, Viral | Major topic |
| Recombination, Genetic | Major topic |
| Simian virus 40 | Major topic |
| Animals | |
| Cell Line | |
| Chlorocebus aethiops | |
| DNA Repair | |
| Kidney | |
| Saccharomyces cerevisiae | |
| Sequence Homology, Nucleic Acid | |
| Transfection |
Source PubMed
Cited by51
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 90 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39266679 | AR coactivators, CBP/p300, are critical mediators of DNA repair in prostate cancer. | Oncogene | 2024 | https://conductscience.org/library/papers/39266679 | PubMed |
| 38766099 | AR coactivators, CBP/p300, are critical mediators of DNA repair in prostate cancer. | bioRxiv | 2024 | https://conductscience.org/library/papers/38766099 | PubMed |
| 36982266 | Long-Term Evaluation of Retinal Morphology and Function in Rosa26-Cas9 Knock-In Mice. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36982266 | PubMed |
| 35972367 | Developing Bottom-Up Induced Pluripotent Stem Cell Derived Solid Tumor Models Using Precision Genome Editing Technologies. | CRISPR J | 2022 | https://conductscience.org/library/papers/35972367 | PubMed |
| 35672603 | Application of CRISPR-Mediated Gene Editing for Crop Improvement. | Mol Biotechnol | 2022 | https://conductscience.org/library/papers/35672603 | PubMed |
| 33535527 | Advances and Obstacles in Homology-Mediated Gene Editing of Hematopoietic Stem Cells. | J Clin Med | 2021 | https://conductscience.org/library/papers/33535527 | PubMed |
| 30728464 | A pipeline for rapidly generating genetically engineered mouse models of pancreatic cancer using in vivo CRISPR-Cas9-mediated somatic recombination. | Lab Invest | 2019 | https://conductscience.org/library/papers/30728464 | PubMed |
| 28791314 | Generation of a Vero-Based Packaging Cell Line to Produce SV40 Gene Delivery Vectors for Use in Clinical Gene Therapy Studies. | Mol Ther Methods Clin Dev | 2017 | https://conductscience.org/library/papers/28791314 | PubMed |
| 28573077 | CRISPR-Cas Genome Surgery in Ophthalmology. | Transl Vis Sci Technol | 2017 | https://conductscience.org/library/papers/28573077 | PubMed |
| 28008168 | Cornerstones of CRISPR-Cas in drug discovery and therapy. | Nat Rev Drug Discov | 2017 | https://conductscience.org/library/papers/28008168 | PubMed |
| 25263330 | CRISPR-Cas9 knockin mice for genome editing and cancer modeling. | Cell | 2014 | https://conductscience.org/library/papers/25263330 | PubMed |
| 24097900 | Repair of strand breaks by homologous recombination. | Cold Spring Harb Perspect Biol | 2013 | https://conductscience.org/library/papers/24097900 | PubMed |
| 23657240 | Molecular evolution of human adenoviruses. | Sci Rep | 2013 | https://conductscience.org/library/papers/23657240 | PubMed |
| 20216527 | Frequent endonuclease cleavage at off-target locations in vivo. | Mol Ther | 2010 | https://conductscience.org/library/papers/20216527 | PubMed |
| 18759011 | Increased gene targeting in Ku70 and Xrcc4 transiently deficient human somatic cells. | Mol Biotechnol | 2009 | https://conductscience.org/library/papers/18759011 | PubMed |
| 10618711 | Maintenance of genomic integrity by p53: complementary roles for activated and non-activated p53. | Oncogene | 1999 | https://conductscience.org/library/papers/10618711 | PubMed |
| 10455437 | Gene targeting is enhanced in human cells overexpressing hRAD51. | Gene Ther | 1999 | https://conductscience.org/library/papers/10455437 | PubMed |
| 9869637 | Double-strand break repair by interchromosomal recombination: suppression of chromosomal translocations. | Genes Dev | 1998 | https://conductscience.org/library/papers/9869637 | PubMed |
| 9819809 | A comparison of calcium phosphate coprecipitation and electroporation. Implications for studies on the genetic effects of DNA damage. | Mol Biotechnol | 1998 | https://conductscience.org/library/papers/9819809 | PubMed |
| 9560248 | Homology-directed repair is a major double-strand break repair pathway in mammalian cells. | Proc Natl Acad Sci U S A | 1998 | https://conductscience.org/library/papers/9560248 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3000612
GET https://conductscience.org/api/papers/v1/3000612/cited_by?page=2